NDC 70518-2091-1 - HydrALAZINE Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2091
- Requested NDC
- 70518-2091-1
- Package NDCs from labels
- 70518-2091-1, 70518-2091-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2019-11-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HydrALAZINE HYDROCHLORIDE TABLETS, USP | REMEDYREPACK INC. | 2019-11-12 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 4ELV7Z65AP |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | e617023e-b060-4db9-a97e-e2b11a37901e | 2023-08-28 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 62475f78-5410-43c2-a11d-54a8363c3ae1 | 2023-07-25 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 7979c865-737d-d999-e053-2a91aa0abc5e | 2023-05-16 | Warnings, Adverse reactions | FD171B778Y |
| HydrALAZINE hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d89d981d-64cf-7321-e053-2995a90aab4a | 2023-05-03 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | dd2cd8a1-7bdd-05e4-e053-2995a90ad366 | 2023-05-02 | Warnings, Adverse reactions | FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 3a7562a8-2f67-4411-ac4a-ab7924193e82 | 2022-12-29 | Warnings, Adverse reactions | 905225 905395 905222 FD171B778Y |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c3797028-c625-4f70-ae69-8a5f6f23f1b8 | 2022-08-09 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 8223c44a-73a9-4da5-a468-d1d8bdb0bbd6 | 2022-05-18 | Warnings, Adverse reactions | FD171B778Y |
| isosorbide dinitrate and hydralazine hydrochloride | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | Wilshire Pharmaceuticals | 620a0680-aad0-4923-84be-7393c0cbdcbd | 2022-04-14 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 149fa857-30ad-451d-b6e2-0000483ccc97 | 2021-03-12 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 500b7f76-5f4e-4e7d-85c3-18b9f66d7504 | 2021-03-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | 811831f9-a844-463a-874d-fb8407659f0b | 2020-09-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 63f388e0-9f3d-4902-990c-9a105aa098ad | 2020-09-01 | Warnings, Adverse reactions | 905225 FD171B778Y |
| a8d4782c-e212-646b-e053-2a95a90a015c | 9105ac8b-852e-46b8-890a-78b72eed2e9b | 2020-06-24 | Warnings, Adverse reactions | 9105ac8b-852e-46b8-890a-78b72eed2e9b | ||
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | dfd60a79-2a30-41e6-b000-a144730099a8 | 2019-10-01 | Warnings, Adverse reactions | ANDA200770 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 48cf71dd-19dc-4239-9117-ebcf9731a45d | 2019-10-01 | Warnings, Adverse reactions | 905199 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | American Regent, Inc. | 17210abc-58f6-442e-8ff2-7971333c82f6 | 2019-05-06 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | 905225 FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.